Mitochondrial impairment in p53-deficient human cancer cells

Shaoyu Zhou, Sushant Kachhap, Keshav K. Singh

Research output: Contribution to journalArticlepeer-review


The mechanism linking p53 inactivation to human cell malignancy remains unclear. Studies have indicated that mitochondrial dysfunction is involved in carcinogenesis. In this study we investigated the role of p53 in mitochondrial DNA (mtDNA) mutation and maintenance of proper mitochondrial function. We measured mtDNA mutation and found no difference in frequency of mutation between the p53+/+ and p53-/- cell lines. However, mitochondrial cytochrome c oxidase (COX) activity was significantly diminished in p53-/- cells. This decrease in COX activity was attributed to decreased protein levels of the COXII subunit encoded by the mitochondrial genome and was not due to mutation in the mitochondrial COXII gene. Further investigation revealed no concomitant decrease in COXII mRNA levels in p53-/- cells and the stability of mRNA in p53-/- cells was unaffected. This study suggests that decreased COX activity is likely due to post-transcriptional regulation of the COXII subunit by p53. COX is a critical enzyme in the mitochondrial electron transport chain and reduced COX activity may affect mitochondrial structure. However, examination of mitochondrial ultrastructure revealed no obvious differences between p53+/+ and p53-/- cell lines. Together, our study suggests that p53 is involved in regulation of COXII at the protein level but not at the mRNA level. p53 does not affect mtDNA mutation or mitochondrial ultrastructure.

Original languageEnglish (US)
Pages (from-to)287-292
Number of pages6
Issue number3
StatePublished - May 2003

ASJC Scopus subject areas

  • Genetics
  • Toxicology
  • Genetics(clinical)
  • Health, Toxicology and Mutagenesis


Dive into the research topics of 'Mitochondrial impairment in p53-deficient human cancer cells'. Together they form a unique fingerprint.

Cite this